Your browser doesn't support javascript.
loading
Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell-Dependent Tumor Activity.
Watanabe, Tsubasa; Gaedicke, Simone; Guffart, Elena; Firat, Elke; Niedermann, Gabriele.
Afiliação
  • Watanabe T; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gaedicke S; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.
  • Guffart E; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Firat E; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Niedermann G; Faculty of Biology, University of Freiburg, Freiburg, Germany.
Clin Cancer Res ; 26(4): 945-956, 2020 02 15.
Article em En | MEDLINE | ID: mdl-31694834

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triptofano / Melanoma Experimental / Células Matadoras Naturais / Linfócitos T CD8-Positivos / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triptofano / Melanoma Experimental / Células Matadoras Naturais / Linfócitos T CD8-Positivos / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article